SYS ONLINE
Supplements/Compound

Myo-Inositol (High-Dose)

High-dose for psychiatric uses.

Buy

Overview

High-dose for psychiatric uses.

Natural sources
  • Endogenously produced or biosynthesized molecule
  • Standardized pharmaceutical- or food-grade supplement
  • Combined with cofactors that improve absorption or activity
Common forms
  • Capsule or softgel
  • Powder
  • Sublingual or buccal
  • Liposomal liquid

Mechanism of action

Second messenger for serotonin and insulin.

Pathways
  • · Second messenger for serotonin
  • · insulin

Effects on the body

Supports
May reduce panic attacks

Organ system effects

Brain & CNS

Myo-Inositol (High-Dose) modulates monoaminergic and GABAergic tone relevant to mood and anxiety regulation.

Evidence-based benefits

May reduce panic attacks

Moderate evidence

Potential side effects

Common
  • · GI upset
Rare
    Serious

      Drug interactions

      Prescription medications (general)
      Always disclose Myo-Inositol (High-Dose) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
      minor

      Supplement interactions

      Pairs well with
      • A high-quality multivitamin
        Covers micronutrient cofactors that support most supplement pathways.
      • Omega-3 (EPA/DHA)
        Foundational anti-inflammatory support that complements most regimens.
      Avoid combining with

      No specific avoidances listed.

      Dosing & bioavailability

      Typical dose
      12–18 g
      Best form
      Most evidence is based on the capsule or softgel form.
      Timing
      Consistent daily timing recommended; split larger doses if GI tolerance is a concern.
      With food?
      With a meal containing fat for fat-soluble compounds; otherwise either.

      Where to buy

      Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.

      Scientific evidence8Show studies
      RCTAm J Psychiatry · 1995

      Inositol for panic disorder

      Benjamin J, et al.

      21 panic patients

      Key findings

      Reduced attack frequency vs placebo.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Myo-Inositol (High-Dose) — May reduce panic attacks

      Live PubMed search

      Live results for "Myo-Inositol (High-Dose) May reduce panic attacks" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Myo-Inositol (High-Dose) and "May reduce panic attacks". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Myo-Inositol (High-Dose) — randomized controlled trial

      Live PubMed search

      Live results for "Myo-Inositol (High-Dose) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Myo-Inositol (High-Dose) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Myo-Inositol (High-Dose) — meta-analysis

      Live PubMed search

      Live results for "Myo-Inositol (High-Dose) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Myo-Inositol (High-Dose) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Myo-Inositol (High-Dose) — pharmacokinetics

      Live PubMed search

      Live results for "Myo-Inositol (High-Dose) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Myo-Inositol (High-Dose) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Myo-Inositol (High-Dose) — safety adverse events

      Live PubMed search

      Live results for "Myo-Inositol (High-Dose) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Myo-Inositol (High-Dose) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Myo-Inositol (High-Dose) — dose response

      Live PubMed search

      Live results for "Myo-Inositol (High-Dose) dose response" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Myo-Inositol (High-Dose) and "dose response". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewGoogle Scholar · 1970

      Google Scholar: Myo-Inositol (High-Dose) — clinical evidence

      Live Scholar search

      Cross-database citation index for Myo-Inositol (High-Dose) as it relates to "clinical evidence".

      Key findings

      Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

      Open study
      Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.

      Community discussion

      (0 threads)

      Share your experience or read what others have tried. Anecdotes are not medical advice.

      Sign in or create a free account to post or reply.
      Loading discussion…